Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Vaccines

  Free Subscription


Articles published in JAMA

Retrieve available abstracts of 249 articles:
HTML format



Single Articles


    June 2022
  1. ABBASI J
    COVID-19 mRNA Vaccine Booster During Pregnancy Increases Maternal and Fetal Antibodies.
    JAMA. 2022 Jun 22. pii: 2793740. doi: 10.1001/jama.2022.11145.
    PubMed    


  2. LARKIN HD
    mRNA COVID-19 Vaccine Booster After Inactivated Vaccine Primary Series.
    JAMA. 2022;327:2280.
    PubMed    


  3. LARKIN HD
    Maternal RSV Vaccine Could Protect Infants, Interim Analysis Suggests.
    JAMA. 2022;327:2182.
    PubMed    


  4. KATZ SE, Edwards K
    Protecting Children Against Omicron.
    JAMA. 2022;327:2195-2197.
    PubMed    


  5. JONES JM, Opsomer JD, Stone M, Benoit T, et al
    Updated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Estimates Based on Blood Donations, July 2020-December 2021.
    JAMA. 2022 Jun 13. pii: 2793517. doi: 10.1001/jama.2022.9745.
    PubMed    


  6. LI Y
    Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave.
    JAMA. 2022;327:2147-2148.
    PubMed    


  7. TAI CG, Maragakis LL, Connolly S, DiFiori J, et al
    Association Between COVID-19 Booster Vaccination and Omicron Infection in a Highly Vaccinated Cohort of Players and Staff in the National Basketball Association.
    JAMA. 2022 Jun 2. pii: 2793169. doi: 10.1001/jama.2022.9479.
    PubMed    


  8. RUBIN R
    Challenges of Deciding Whether and How to Update COVID-19 Vaccines to Protect Against Variants.
    JAMA. 2022 Jun 1. pii: 2793149. doi: 10.1001/jama.2022.9367.
    PubMed    


    May 2022
  9. WEISS SR
    Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US.
    JAMA. 2022;327:2019-2020.
    PubMed    


  10. OSTER ME, Shay DK, Shimabukuro TT
    Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US-Reply.
    JAMA. 2022;327:2020-2021.
    PubMed    


  11. KUEHN BM
    Cardiac Complications More Common After COVID-19 Than Vaccination.
    JAMA. 2022;327:1951.
    PubMed    


  12. FLEMING-DUTRA KE, Britton A, Shang N, Derado G, et al
    Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.
    JAMA. 2022 May 13. pii: 2792524. doi: 10.1001/jama.2022.7493.
    PubMed     Abstract available


  13. DORABAWILA V, Hoefer D, Bauer UE, Bassett MT, et al
    Risk of Infection and Hospitalization Among Vaccinated and Unvaccinated Children and Adolescents in New York After the Emergence of the Omicron Variant.
    JAMA. 2022 May 13. pii: 2792525. doi: 10.1001/jama.2022.7319.
    PubMed    


  14. LARKIN HD
    Four Vaccine Doses Prevented Severe Omicron COVID-19 Better Than 3.
    JAMA. 2022;327:1748.
    PubMed    


  15. LARKIN HD
    Two mRNA COVID-19 Vaccines Stimulate Different Immune Responses.
    JAMA. 2022;327:1748.
    PubMed    


  16. KUEHN BM
    Age Range Is Expanded for Universal Hepatitis B Vaccination.
    JAMA. 2022;327:1749.
    PubMed    


  17. KUEHN BM
    mRNA Booster Improves a COVID-19 Vaccine's Effectiveness.
    JAMA. 2022;327:1749.
    PubMed    


  18. SLOMSKI A
    Studies Examine Risk of Hearing Loss After COVID-19 Vaccination.
    JAMA. 2022;327:1641.
    PubMed    


  19. MARKS P, Woodcock J, Califf R
    COVID-19 Vaccination-Becoming Part of the New Normal.
    JAMA. 2022 May 2. pii: 2792030. doi: 10.1001/jama.2022.7469.
    PubMed    


    April 2022
  20. KUEHN BM
    COVID-19 Vaccine Effectiveness in Youth Varies by Age, Variant.
    JAMA. 2022;327:1540.
    PubMed    


  21. RAZZAGHI H, Meghani M, Crane B, Ellington S, et al
    Receipt of COVID-19 Booster Dose Among Fully Vaccinated Pregnant Individuals Aged 18 to 49 Years by Key Demographics.
    JAMA. 2022 Apr 22. pii: 2791659. doi: 10.1001/jama.2022.6834.
    PubMed    


  22. LARKIN HD
    Fractionating COVID-19 Vaccine Doses May Save Lives.
    JAMA. 2022;327:1438.
    PubMed    


  23. WOLFSON AR, Freeman EE, Blumenthal KG
    Urticaria 12 Days After COVID-19 mRNA Booster Vaccination.
    JAMA. 2022 Apr 14. pii: 2791317. doi: 10.1001/jama.2022.5247.
    PubMed    


  24. ABBASI J
    Large US Study Examines First 6 Months of COVID-19 Vaccine Safety Data.
    JAMA. 2022;327:1323.
    PubMed    


  25. ABBASI J
    Vaccine Booster Dose Appears to Reduce Omicron Hospitalizations.
    JAMA. 2022;327:1323.
    PubMed    


  26. KUEHN BM
    Myocarditis Adverse Event Less Common After COVID-19 Vaccine Booster.
    JAMA. 2022;327:1324.
    PubMed    


  27. SLOMSKI A
    Maternal COVID-19 Vaccine Safe for Infants.
    JAMA. 2022;327:1218.
    PubMed    


  28. NISSEN SE, Wolski K, Balog C, Swerdlow DI, et al
    Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels.
    JAMA. 2022 Apr 3. pii: 2790912. doi: 10.1001/jama.2022.5050.
    PubMed     Abstract available


  29. NATTINO G, Castiglioni S, Cereda D, Della Valle PG, et al
    Association Between SARS-CoV-2 Viral Load in Wastewater and Reported Cases, Hospitalizations, and Vaccinations in Milan, March 2020 to November 2021.
    JAMA. 2022 Apr 1. pii: 2790911. doi: 10.1001/jama.2022.4908.
    PubMed    


    March 2022
  30. BRUXVOORT K, Slezak J, Qian L, Sy LS, et al
    Association Between 2-Dose vs 3-Dose Hepatitis B Vaccine and Acute Myocardial Infarction.
    JAMA. 2022 Mar 25. pii: 2790492. doi: 10.1001/jama.2022.2540.
    PubMed     Abstract available


  31. KHARBANDA EO, Vazquez-Benitez G
    COVID-19 mRNA Vaccines During Pregnancy: New Evidence to Help Address Vaccine Hesitancy.
    JAMA. 2022 Mar 24. pii: 2790610. doi: 10.1001/jama.2022.2459.
    PubMed    


  32. MAGNUS MC, Ortqvist AK, Dahlqwist E, Ljung R, et al
    Association of SARS-CoV-2 Vaccination During Pregnancy With Pregnancy Outcomes.
    JAMA. 2022 Mar 24. pii: 2790608. doi: 10.1001/jama.2022.3271.
    PubMed     Abstract available


  33. FELL DB, Dhinsa T, Alton GD, Torok E, et al
    Association of COVID-19 Vaccination in Pregnancy With Adverse Peripartum Outcomes.
    JAMA. 2022 Mar 24. pii: 2790607. doi: 10.1001/jama.2022.4255.
    PubMed     Abstract available


  34. SLOMSKI A
    Pneumococcal Vaccine Induces Immune Responses to 20 Serotypes.
    JAMA. 2022;327:1118.
    PubMed    


  35. STEAD W
    One Person.
    JAMA. 2022;327:1131-1132.
    PubMed    


  36. FRIEDENSOHN L, Levin D, Fadlon-Derai M, Gershovitz L, et al
    Myocarditis Following a Third BNT162b2 Vaccination Dose in Military Recruits in Israel.
    JAMA. 2022 Mar 17. pii: 2790421. doi: 10.1001/jama.2022.4425.
    PubMed    


  37. ABBASI J
    First mRNA HIV Vaccine Clinical Trial Launches.
    JAMA. 2022;327:909.
    PubMed    


  38. KUEHN BM
    Racial and Ethnic, Gender Disparities Seen in LGBT COVID-19 Vaccination Rates.
    JAMA. 2022;327:910.
    PubMed    


    February 2022
  39. ABBASI J
    Widespread Misinformation About Infertility Continues to Create COVID-19 Vaccine Hesitancy.
    JAMA. 2022 Feb 22. pii: 2789477. doi: 10.1001/jama.2022.2404.
    PubMed    


  40. KUEHN BM
    New COVID-19 Vaccine Aims to Increase Global Vaccine Access.
    JAMA. 2022;327:614.
    PubMed    


  41. KUEHN BM
    COVID-19 Vaccines Safe, Effective in Rheumatic Diseases.
    JAMA. 2022;327:614.
    PubMed    


  42. BRITTON A, Fleming-Dutra KE, Shang N, Smith ZR, et al
    Association of COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection by Time Since Vaccination and Delta Variant Predominance.
    JAMA. 2022 Feb 14. pii: 2789294. doi: 10.1001/jama.2022.2068.
    PubMed     Abstract available


  43. TAN SHX, Pung R, Wang LF, Lye DC, et al
    Association of Homologous and Heterologous Vaccine Boosters With COVID-19 Incidence and Severity in Singapore.
    JAMA. 2022 Feb 11. pii: 2789151. doi: 10.1001/jama.2022.1922.
    PubMed    


  44. ABBASI J
    Fourth COVID-19 Vaccine Dose Increases Low Antibodies.
    JAMA. 2022;327:517.
    PubMed    


  45. KUEHN BM
    Health Care Professionals' Advice Can Increase COVID-19 Vaccination.
    JAMA. 2022;327:518.
    PubMed    


  46. SHOOK LL, Atyeo CG, Yonker LM, Fasano A, et al
    Durability of Anti-Spike Antibodies in Infants After Maternal COVID-19 Vaccination or Natural Infection.
    JAMA. 2022 Feb 7. pii: 2788986. doi: 10.1001/jama.2022.1206.
    PubMed    


    January 2022
  47. SURAN M
    Coverage of COVID-19 Vaccine Counseling for Children and Youths.
    JAMA. 2022;327:313.
    PubMed    


  48. LI HF, Hu SM, Lv M
    Association of Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barre Syndrome.
    JAMA. 2022;327:392-393.
    PubMed    


  49. WOO EJ, Dimova RB, Mba-Jonas A
    Presumptive Guillain-Barre Syndrome Associated With Receipt of the Ad26.COV2.2.S COVID-19 Vaccine-Reply.
    JAMA. 2022;327:393-394.
    PubMed    


  50. OSTER ME, Shay DK, Su JR, Gee J, et al
    Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021.
    JAMA. 2022;327:331-340.
    PubMed     Abstract available


  51. KLOMPAS M, Karan A
    Preventing SARS-CoV-2 Transmission in Health Care Settings in the Context of the Omicron Variant.
    JAMA. 2022 Jan 24. pii: 2788503. doi: 10.1001/jama.2022.0262.
    PubMed    


  52. ABBASI J, Rubin R, Suran M
    How the Supreme Court's COVID-19 Vaccine Mandate Rulings Could Shape the Pandemic's Next Phase.
    JAMA. 2022 Jan 21. pii: 2788486. doi: 10.1001/jama.2022.0791.
    PubMed    


  53. OMER SB, Malani PN
    Booster Vaccination to Prevent COVID-19 in the Era of Omicron: An Effective Part of a Layered Public Health Approach.
    JAMA. 2022 Jan 21. pii: 2788487. doi: 10.1001/jama.2022.0892.
    PubMed    


  54. GOSTIN LO, Parmet WE, Rosenbaum S
    The US Supreme Court's Rulings on Large Business and Health Care Worker Vaccine Mandates: Ramifications for the COVID-19 Response and the Future of Federal Public Health Protection.
    JAMA. 2022 Jan 21. pii: 2788481. doi: 10.1001/jama.2022.0852.
    PubMed    


  55. ACCORSI EK, Britton A, Fleming-Dutra KE, Smith ZR, et al
    Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    JAMA. 2022 Jan 21. pii: 2788485. doi: 10.1001/jama.2022.0470.
    PubMed     Abstract available


  56. WANG L, Davis PB, Kaelber DC, Volkow ND, et al
    Comparison of mRNA-1273 and BNT162b2 Vaccines on Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Death During the Delta-Predominant Period.
    JAMA. 2022 Jan 20. pii: 2788408. doi: 10.1001/jama.2022.0210.
    PubMed    


  57. KUEHN BM
    Vaccine Development Is Charting a New Path in Malaria Control.
    JAMA. 2022 Jan 19. pii: 2788387. doi: 10.1001/jama.2021.20627.
    PubMed    


  58. KUEHN BM
    Vaccine Passports Help Boost Lagging Vaccination Rates.
    JAMA. 2022;327:209.
    PubMed    


  59. ADASHI EY, Cohen IG
    The Pandemic Preparedness Program: Reimagining Public Health.
    JAMA. 2022;327:219-220.
    PubMed    


  60. ABBASI J
    Former Biden-Harris Transition Advisors Propose a New National Strategy for COVID-19.
    JAMA. 2022 Jan 18. pii: 2788316. doi: 10.1001/jama.2022.0216.
    PubMed    


  61. RUBIN R
    COVID-19 Vaccines Have Been Available in the US for More Than a Year-What's Been Learned and What's Next?
    JAMA. 2022 Jan 11. pii: 2788213. doi: 10.1001/jama.2022.0106.
    PubMed    


  62. ABBASI J
    Studies Suggest COVID-19 Vaccine Boosters Save Lives.
    JAMA. 2022;327:115.
    PubMed    


  63. ABBASI J
    Homing In On a SARS-CoV-2 Correlate of Protection.
    JAMA. 2022;327:115.
    PubMed    


  64. ABBASI J
    COVID-19 Vaccine Focused on T-Cell Response Promising in Early Trial.
    JAMA. 2022;327:115.
    PubMed    


  65. WALD A
    Booster Vaccination to Reduce SARS-CoV-2 Transmission and Infection.
    JAMA. 2022 Jan 10. pii: 2788105. doi: 10.1001/jama.2021.23726.
    PubMed    


  66. SPITZER A, Angel Y, Marudi O, Zeltser D, et al
    Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.
    JAMA. 2022 Jan 10. pii: 2788104. doi: 10.1001/jama.2021.23641.
    PubMed     Abstract available


  67. BORIO LL, Bright RA, Emanuel EJ
    A National Strategy for COVID-19 Medical Countermeasures: Vaccines and Therapeutics.
    JAMA. 2022 Jan 6. pii: 2787946. doi: 10.1001/jama.2021.24165.
    PubMed    


    December 2021
  68. ABBASI J
    RSV Vaccines, Finally Within Reach, Could Prevent Tens of Thousands of Yearly Deaths.
    JAMA. 2021 Dec 29. pii: 2787757. doi: 10.1001/jama.2021.23772.
    PubMed    



  69. Two New Pneumococcal Vaccines-Prevnar 20 and Vaxneuvance.
    JAMA. 2021;326:2521-2522.
    PubMed    


  70. SLOMSKI A
    More Pediatric Data for First Cell-Derived Influenza Vaccine.
    JAMA. 2021;326:2464.
    PubMed    


  71. KUEHN BM
    Influenza Vaccination Increased During the COVID-19 Pandemic.
    JAMA. 2021;326:2465.
    PubMed    


  72. ABBASI J
    Omicron Has Reached the US-Here's What Infectious Disease Experts Know About the Variant.
    JAMA. 2021;326:2460-2462.
    PubMed    


  73. LAM DL, Flanagan MR
    Axillary Lymphadenopathy After COVID-19 Vaccination in a Woman With Breast Cancer.
    JAMA. 2021 Dec 23. pii: 2787650. doi: 10.1001/jama.2021.20010.
    PubMed    


  74. DEL RIO C, Omer SB, Malani PN
    Winter of Omicron-The Evolving COVID-19 Pandemic.
    JAMA. 2021 Dec 22. pii: 2787609. doi: 10.1001/jama.2021.24315.
    PubMed    


  75. KUEHN BM
    Vaccination Doesn't Eliminate Delta Variant Household Transmission.
    JAMA. 2021;326:2353.
    PubMed    


  76. COHN AC, Mahon BE, Walensky RP
    One Year of COVID-19 Vaccines: A Shot of Hope, a Dose of Reality.
    JAMA. 2021 Dec 21. pii: 2787504. doi: 10.1001/jama.2021.23962.
    PubMed    


  77. LEVY M, Recher M, Hubert H, Javouhey E, et al
    Multisystem Inflammatory Syndrome in Children by COVID-19 Vaccination Status of Adolescents in France.
    JAMA. 2021 Dec 20. pii: 2787495. doi: 10.1001/jama.2021.23262.
    PubMed    


  78. ADAMS LE, Waterman S, Paz-Bailey G
    Vaccination for Dengue Prevention.
    JAMA. 2021 Dec 16. pii: 2787445. doi: 10.1001/jama.2021.23466.
    PubMed    


  79. BATES TA, McBride SK, Winders B, Schoen D, et al
    Antibody Response and Variant Cross-Neutralization After SARS-CoV-2 Breakthrough Infection.
    JAMA. 2021 Dec 16. pii: 2787447. doi: 10.1001/jama.2021.22898.
    PubMed    


  80. SURAN M
    Why Parents Still Hesitate to Vaccinate Their Children Against COVID-19.
    JAMA. 2021 Dec 15. pii: 2787289. doi: 10.1001/jama.2021.21625.
    PubMed    


  81. ABBASI J
    COVID-19 Vaccine Combination Was Superior in Real-world Study.
    JAMA. 2021;326:2250.
    PubMed    


  82. WALTER K
    COVID-19 and Pregnancy.
    JAMA. 2021 Dec 10. pii: 2787240. doi: 10.1001/jama.2021.22679.
    PubMed    



  83. Current Comment.
    JAMA. 2021;326:2217.
    PubMed    


  84. GRUNAU B, Goldfarb DM, Asamoah-Boaheng M, Golding L, et al
    Immunogenicity of Extended mRNA SARS-CoV-2 Vaccine Dosing Intervals.
    JAMA. 2021 Dec 3. pii: 2786992. doi: 10.1001/jama.2021.21921.
    PubMed    


  85. ABBASI J
    Data Emerge From the UK's COVID-19 Vaccine Extended Dosing Interval.
    JAMA. 2021 Dec 3. pii: 2786993. doi: 10.1001/jama.2021.21963.
    PubMed    


  86. FERNANDES B, Navin MC, Reiss DR, Omer SB, et al
    US State-Level Legal Interventions Related to COVID-19 Vaccine Mandates.
    JAMA. 2021 Dec 2. pii: 2786984. doi: 10.1001/jama.2021.22122.
    PubMed    


    November 2021
  87. RUBIN R
    COVID-19 Vaccine Makers Plan for Annual Boosters, but It's Not Clear They'll Be Needed.
    JAMA. 2021 Nov 24. pii: 2786818. doi: 10.1001/jama.2021.21291.
    PubMed    


  88. RUBIN R
    Substance Use Disorders and COVID-19 Vaccine Response.
    JAMA. 2021;326:2000.
    PubMed    


  89. KUEHN BM
    COVID-19 Vaccine Highly Effective Against Adolescent Hospitalizations.
    JAMA. 2021;326:2002.
    PubMed    


  90. KUEHN BM
    Unhygienic Practices Lead to Routine Vaccination-Linked Infections.
    JAMA. 2021;326:2002.
    PubMed    


  91. JABAGI MJ, Botton J, Bertrand M, Weill A, et al
    Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older.
    JAMA. 2021 Nov 22. pii: 2786667. doi: 10.1001/jama.2021.21699.
    PubMed    


  92. SFEIR MM, Snayd M
    Serologic Testing for Hepatitis B.
    JAMA. 2021 Nov 19. pii: 2786654. doi: 10.1001/jama.2021.19803.
    PubMed    


  93. CHOR J, Davis AM, Rusiecki JM
    Cervical Cancer Screening Guideline for Individuals at Average Risk.
    JAMA. 2021 Nov 12. pii: 2786400. doi: 10.1001/jama.2021.13448.
    PubMed    


  94. ABBASI J
    Flu Vaccine Candidate Elicits Enhanced Immune Response.
    JAMA. 2021;326:1784.
    PubMed    


  95. ABBASI J
    Pfizer Launches Phase 1 mRNA Flu Vaccine Trial.
    JAMA. 2021;326:1784.
    PubMed    


  96. ABBASI J
    "Polymutant" Spike Points Way Toward More Durable COVID-19 Vaccine.
    JAMA. 2021;326:1784.
    PubMed    



  97. Routine Smallpox Vaccination.
    JAMA. 2021;326:1876.
    PubMed    


  98. ELIAKIM-RAZ N, Leibovici-Weisman Y, Stemmer A, Ness A, et al
    Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged >/=60 Years.
    JAMA. 2021 Nov 5. pii: 2786096. doi: 10.1001/jama.2021.19885.
    PubMed    


  99. MOSS WJ, Gostin LO, Nuzzo JB
    Pediatric COVID-19 Vaccines: What Parents, Practitioners, and Policy Makers Need to Know.
    JAMA. 2021 Nov 5. pii: 2786095. doi: 10.1001/jama.2021.20734.
    PubMed    


  100. KLOMPAS M
    Understanding Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination.
    JAMA. 2021 Nov 4. pii: 2786040. doi: 10.1001/jama.2021.19063.
    PubMed    


  101. TENFORDE MW, Self WH, Adams K, Gaglani M, et al
    Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.
    JAMA. 2021 Nov 4. pii: 2786039. doi: 10.1001/jama.2021.19499.
    PubMed     Abstract available


  102. CROWE EH
    The Taste of Hope.
    JAMA. 2021;326:1683-1684.
    PubMed    


  103. ZHONG D, Xiao S, Debes AK, Egbert ER, et al
    Durability of Antibody Levels After Vaccination With mRNA SARS-CoV-2 Vaccine in Individuals With or Without Prior Infection.
    JAMA. 2021 Nov 1. pii: 2785919. doi: 10.1001/jama.2021.19996.
    PubMed    


  104. ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, Yassine HM, et al
    Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar.
    JAMA. 2021 Nov 1. pii: 2785918. doi: 10.1001/jama.2021.19623.
    PubMed     Abstract available


    October 2021
  105. ABBASI J
    The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity.
    JAMA. 2021 Oct 21. pii: 2785530. doi: 10.1001/jama.2021.18919.
    PubMed    


  106. RUBIN R
    Trying to Block SARS-CoV-2 Transmission With Intranasal Vaccines.
    JAMA. 2021 Oct 14. pii: 2785303. doi: 10.1001/jama.2021.18143.
    PubMed    


  107. SZILAGYI PG, Thomas K, Shah MD, Vizueta N, et al
    Changes in COVID-19 Vaccine Intent From April/May to June/July 2021.
    JAMA. 2021 Oct 13. pii: 2785290. doi: 10.1001/jama.2021.18761.
    PubMed    


  108. ABBASI J
    India's New COVID-19 DNA Vaccine for Adolescents and Adults Is a First.
    JAMA. 2021;326:1365.
    PubMed    


  109. ABBASI J
    Moderna's mRNA Vaccine for Seasonal Flu Enters Clinical Trials.
    JAMA. 2021;326:1365.
    PubMed    


  110. ABBASI J
    Vaccine-Induced SARS-CoV-2 Antibodies in Inflammatory Diseases.
    JAMA. 2021;326:1365.
    PubMed    


  111. KUEHN BM
    HPV Vaccination Coverage Has Increased Among Adolescents.
    JAMA. 2021;326:1366.
    PubMed    


  112. WOO EJ, Mba-Jonas A, Dimova RB, Alimchandani M, et al
    Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barre Syndrome, February-July 2021.
    JAMA. 2021 Oct 7. pii: 2785009. doi: 10.1001/jama.2021.16496.
    PubMed     Abstract available


    September 2021
  113. RUBIN R
    COVID-19 Vaccine Nasal Spray.
    JAMA. 2021;326:1138.
    PubMed    


  114. KRONMAL SL
    Shots in Arms.
    JAMA. 2021;326:1151-1152.
    PubMed    


  115. ABBASI J
    SARS-CoV-2 Variant Antibodies Wane 6 Months After Vaccination.
    JAMA. 2021;326:901.
    PubMed    


  116. KUEHN BM
    Adolescent Myocarditis After COVID-19 Vaccination Is Rare.
    JAMA. 2021;326:902.
    PubMed    


  117. KHARBANDA EO, Haapala J, DeSilva M, Vazquez-Benitez G, et al
    Spontaneous Abortion Following COVID-19 Vaccination During Pregnancy.
    JAMA. 2021 Sep 8. pii: 2784193. doi: 10.1001/jama.2021.15494.
    PubMed    


  118. SLOMSKI A
    Most Fully Vaccinated Patients With Cancer Have SARS-CoV-2 Antibodies.
    JAMA. 2021;326:800.
    PubMed    


  119. BLUMENTHAL KG, Phadke NA, Bates DW
    Safety Surveillance of COVID-19 mRNA Vaccines Through the Vaccine Safety Datalink.
    JAMA. 2021 Sep 3. pii: 2784017. doi: 10.1001/jama.2021.14808.
    PubMed    


  120. KLEIN NP, Lewis N, Goddard K, Fireman B, et al
    Surveillance for Adverse Events After COVID-19 mRNA Vaccination.
    JAMA. 2021 Sep 3. pii: 2784015. doi: 10.1001/jama.2021.15072.
    PubMed     Abstract available


  121. JONES JM, Stone M, Sulaeman H, Fink RV, et al
    Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.
    JAMA. 2021 Sep 2. pii: 2784013. doi: 10.1001/jama.2021.15161.
    PubMed     Abstract available


    August 2021
  122. STEENSELS D, Pierlet N, Penders J, Mesotten D, et al
    Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273.
    JAMA. 2021 Aug 30. pii: 2783797. doi: 10.1001/jama.2021.15125.
    PubMed    


  123. RUBIN R
    Influenza's Unprecedented Low Profile During COVID-19 Pandemic Leaves Experts Wondering What This Flu Season Has in Store.
    JAMA. 2021 Aug 25. pii: 2783644. doi: 10.1001/jama.2021.14131.
    PubMed    


  124. DETSKY AS, Bogoch II
    COVID-19 in Canada: Experience and Response to Waves 2 and 3.
    JAMA. 2021 Aug 23. pii: 2783610. doi: 10.1001/jama.2021.14797.
    PubMed    


  125. DEL RIO C, Malani PN, Omer SB
    Confronting the Delta Variant of SARS-CoV-2, Summer 2021.
    JAMA. 2021 Aug 18. pii: 2783478. doi: 10.1001/jama.2021.14811.
    PubMed    


  126. EVANS A, Webster J, Flores G
    Partnering With the Faith-Based Community to Address Disparities in COVID-19 Vaccination Rates and Outcomes Among US Black and Latino Populations.
    JAMA. 2021;326:609-610.
    PubMed    


  127. SCHAEFER GO, Leland RJ, Emanuel EJ
    Making Vaccines Available to Other Countries Before Offering Domestic Booster Vaccinations.
    JAMA. 2021 Aug 12. pii: 2783234. doi: 10.1001/jama.2021.13226.
    PubMed    


  128. ABBASI J
    Oldest Adults Need 2 mRNA Vaccine Doses to Neutralize SARS-CoV-2.
    JAMA. 2021;326:473.
    PubMed    


  129. ABBASI J
    COVID-19 mRNA Vaccines Blunt Breakthrough Infection Severity.
    JAMA. 2021;326:473.
    PubMed    


  130. DIAZ GA, Parsons GT, Gering SK, Meier AR, et al
    Myocarditis and Pericarditis After Vaccination for COVID-19.
    JAMA. 2021 Aug 4. pii: 2782900. doi: 10.1001/jama.2021.13443.
    PubMed    


    July 2021
  131. ABBASI J
    Uberantibodies From Recovered COVID-19 Patients Could Spur New Therapeutics and Vaccines.
    JAMA. 2021 Jul 28. pii: 2782673. doi: 10.1001/jama.2021.12915.
    PubMed    


  132. RUBIN R
    Higher Medicare Payments for In-home COVID-19 Vaccinations.
    JAMA. 2021;326:298.
    PubMed    


  133. KUEHN BM
    Resurgence of Pertussis Linked With Switch to Acellular Vaccine.
    JAMA. 2021;326:300.
    PubMed    


  134. BENOTMANE I, Gautier G, Perrin P, Olagne J, et al
    Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses.
    JAMA. 2021 Jul 23. pii: 2782538. doi: 10.1001/jama.2021.12339.
    PubMed    


  135. BATES TA, Leier HC, Lyski ZL, Goodman JR, et al
    Age-Dependent Neutralization of SARS-CoV-2 and P.1 Variant by Vaccine Immune Serum Samples.
    JAMA. 2021 Jul 21. pii: 2782428. doi: 10.1001/jama.2021.11656.
    PubMed    


  136. ABBASI J
    Study Suggests Lasting Immunity After COVID-19, With a Big Boost From Vaccination.
    JAMA. 2021 Jul 14. pii: 2782139. doi: 10.1001/jama.2021.11717.
    PubMed    


  137. GOLDSHTEIN I, Nevo D, Steinberg DM, Rotem RS, et al
    Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women.
    JAMA. 2021 Jul 12. pii: 2782047. doi: 10.1001/jama.2021.11035.
    PubMed     Abstract available


  138. NUTI SV, Armstrong K
    Lay Epidemiology and Vaccine Acceptance.
    JAMA. 2021 Jul 7. pii: 2781943. doi: 10.1001/jama.2021.11130.
    PubMed    


  139. WALKEY AJ, Law A, Bosch NA
    Lottery-Based Incentive in Ohio and COVID-19 Vaccination Rates.
    JAMA. 2021 Jul 2. pii: 2781792. doi: 10.1001/jama.2021.11048.
    PubMed    


  140. SANCHEZ VAN KAMMEN M, Heldner MR, Brodard J, Scutelnic A, et al
    Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.
    JAMA. 2021 Jul 2. pii: 2781791. doi: 10.1001/jama.2021.9889.
    PubMed     Abstract available


  141. KAVANAGH MM, Gostin LO, Sunder M
    Sharing Technology and Vaccine Doses to Address Global Vaccine Inequity and End the COVID-19 Pandemic.
    JAMA. 2021 Jul 1. pii: 2781756. doi: 10.1001/jama.2021.10823.
    PubMed    


  142. PERSAD G, Emanuel EJ
    Ethical Considerations of Offering Benefits to COVID-19 Vaccine Recipients.
    JAMA. 2021 Jul 1. pii: 2781755. doi: 10.1001/jama.2021.11045.
    PubMed    


    June 2021
  143. RUBIN R
    The Search for a Single Vaccine Against Coronaviruses Yet to Come.
    JAMA. 2021 Jun 23. pii: 2781521. doi: 10.1001/jama.2021.9477.
    PubMed    


  144. RUBIN R
    Vaccination in Residential Facilities.
    JAMA. 2021;325:2426.
    PubMed    


  145. GONZALEZ DC, Nassau DE, Khodamoradi K, Ibrahim E, et al
    Sperm Parameters Before and After COVID-19 mRNA Vaccination.
    JAMA. 2021 Jun 17. pii: 2781360. doi: 10.1001/jama.2021.9976.
    PubMed    


  146. BERTOLLINI R, Chemaitelly H, Yassine HM, Al-Thani MH, et al
    Associations of Vaccination and of Prior Infection With Positive PCR Test Results for SARS-CoV-2 in Airline Passengers Arriving in Qatar.
    JAMA. 2021 Jun 9. pii: 2781112. doi: 10.1001/jama.2021.9970.
    PubMed    


  147. AZZIZ-BAUMGARTNER E, Grohskopf L, Patel M
    Realizing the Potential of Maternal Influenza Vaccination.
    JAMA. 2021;325:2257-2259.
    PubMed    


  148. MEHRABADI A, Dodds L, MacDonald NE, Top KA, et al
    Association of Maternal Influenza Vaccination During Pregnancy With Early Childhood Health Outcomes.
    JAMA. 2021;325:2285-2293.
    PubMed     Abstract available


  149. TALBOT TR
    COVID-19 Vaccination of Health Care Personnel as a Condition of Employment: A Logical Addition to Institutional Safety Programs.
    JAMA. 2021 Jun 7. pii: 2781011. doi: 10.1001/jama.2021.8901.
    PubMed    


  150. GOSTIN LO, Shaw J, Salmon DA
    Mandatory SARS-CoV-2 Vaccinations in K-12 Schools, Colleges/Universities, and Businesses.
    JAMA. 2021 Jun 7. pii: 2781010. doi: 10.1001/jama.2021.9342.
    PubMed    


  151. RYAN L
    Vaccinated but Not Protected-Living Immunocompromised During the Pandemic.
    JAMA. 2021 Jun 7. pii: 2781012. doi: 10.1001/jama.2021.9321.
    PubMed    


  152. WOOD S, Schulman K
    When Vaccine Apathy, Not Hesitancy, Drives Vaccine Disinterest.
    JAMA. 2021 Jun 2. pii: 2780792. doi: 10.1001/jama.2021.7707.
    PubMed    


    May 2021
  153. HOTEZ PJ, Narayan KMV
    Restoring Vaccine Diplomacy.
    JAMA. 2021 May 28. pii: 2780640. doi: 10.1001/jama.2021.7439.
    PubMed    


  154. AL KAABI N, Zhang Y, Xia S, Yang Y, et al
    Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial.
    JAMA. 2021 May 26. pii: 2780562. doi: 10.1001/jama.2021.8565.
    PubMed     Abstract available


  155. RUBIN R
    Allergic Reactions to mRNA Vaccines.
    JAMA. 2021;325:2038.
    PubMed    


  156. DALY M, Jones A, Robinson E
    Public Trust and Willingness to Vaccinate Against COVID-19 in the US From October 14, 2020, to March 29, 2021.
    JAMA. 2021 May 24. pii: 2780519. doi: 10.1001/jama.2021.8246.
    PubMed    


  157. UYEKI TM, Wentworth DE, Jernigan DB
    Influenza Activity in the US During the 2020-2021 Season.
    JAMA. 2021 May 24. pii: 2780518. doi: 10.1001/jama.2021.6125.
    PubMed    


  158. COLLIER AY, McMahan K, Yu J, Tostanoski LH, et al
    Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women.
    JAMA. 2021 May 13. pii: 2780202. doi: 10.1001/jama.2021.7563.
    PubMed     Abstract available


  159. ABBASI J
    Personalized Cancer Vaccine Approach Safe in Early Trial.
    JAMA. 2021;325:1825.
    PubMed    


  160. KUEHN BM
    Even Partial COVID-19 Vaccination Protects Nursing Home Residents.
    JAMA. 2021;325:1826.
    PubMed    


  161. KUEHN BM
    Vaccine Dramatically Reduces HPV Infection Among Young Women.
    JAMA. 2021;325:1826.
    PubMed    


  162. TANG L, Hijano DR, Gaur AH, Geiger TL, et al
    Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce.
    JAMA. 2021 May 6. pii: 2779854. doi: 10.1001/jama.2021.6564.
    PubMed    


  163. ANGEL Y, Spitzer A, Henig O, Saiag E, et al
    Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
    JAMA. 2021 May 6. pii: 2779853. doi: 10.1001/jama.2021.7152.
    PubMed     Abstract available


  164. BOYARSKY BJ, Werbel WA, Avery RK, Tobian AAR, et al
    Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients.
    JAMA. 2021 May 5. pii: 2779852. doi: 10.1001/jama.2021.7489.
    PubMed    


    April 2021
  165. SEE I, Su JR, Lale A, Woo EJ, et al
    US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021.
    JAMA. 2021 Apr 30. pii: 2779731. doi: 10.1001/jama.2021.7517.
    PubMed     Abstract available


  166. KARRON RA, Key NS, Sharfstein JM
    Assessing a Rare and Serious Adverse Event Following Administration of the Ad26.COV2.S Vaccine.
    JAMA. 2021 Apr 30. pii: 2779732. doi: 10.1001/jama.2021.7637.
    PubMed    


  167. RUBIN R
    Vaccination Priorities Delay Shots for Higher-Risk People of Color.
    JAMA. 2021;325:1601.
    PubMed    


  168. RUBIN R
    Medicare Raises Payment for Administering COVID-19 Vaccines.
    JAMA. 2021;325:1601.
    PubMed    


  169. CHEN MM, Mott N, Clark SJ, Harper DM, et al
    HPV Vaccination Among Young Adults in the US.
    JAMA. 2021;325:1673-1674.
    PubMed    


  170. KUEHN BM
    Israel's Real-life Evidence That Vaccine Can Prevent Severe COVID-19.
    JAMA. 2021;325:1603.
    PubMed    


  171. BLAIN H, Tuaillon E, Gamon L, Pisoni A, et al
    Spike Antibody Levels of Nursing Home Residents With or Without Prior COVID-19 3 Weeks After a Single BNT162b2 Vaccine Dose.
    JAMA. 2021 Apr 15. pii: 2778926. doi: 10.1001/jama.2021.6042.
    PubMed    



  172. Experts Discuss COVID-19-Variants and Vaccine Efficacy, Immunosuppressed Patients, and More.
    JAMA. 2021 Apr 14. pii: 2778876. doi: 10.1001/jama.2021.5938.
    PubMed    


  173. ABBASI J
    Data Leak Exposes Early COVID-19 Vaccine Manufacturing Hiccups.
    JAMA. 2021;325:1385.
    PubMed    


  174. PERL SH, Uzan-Yulzari A, Klainer H, Asiskovich L, et al
    SARS-CoV-2-Specific Antibodies in Breast Milk After COVID-19 Vaccination of Breastfeeding Women.
    JAMA. 2021 Apr 12. pii: 2778766. doi: 10.1001/jama.2021.5782.
    PubMed    


  175. GOSTIN LO, Cohen IG, Shaw J
    Digital Health Passes in the Age of COVID-19: Are "Vaccine Passports" Lawful and Ethical?
    JAMA. 2021 Apr 7. pii: 2778526. doi: 10.1001/jama.2021.5283.
    PubMed    


  176. CHAPIN-BARDALES J, Gee J, Myers T
    Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines.
    JAMA. 2021 Apr 5. pii: 2778441. doi: 10.1001/jama.2021.5374.
    PubMed    


    March 2021
  177. RUBIN R
    HHS Expands Number of People Who Can Vaccinate Against COVID-19.
    JAMA. 2021;325:1134.
    PubMed    


  178. GOSTIN LO
    The Coronavirus Pandemic 1 Year On-What Went Wrong?
    JAMA. 2021;325:1132-1133.
    PubMed    


  179. EDARA VV, Hudson WH, Xie X, Ahmed R, et al
    Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination.
    JAMA. 2021 Mar 19. pii: 2777898. doi: 10.1001/jama.2021.4388.
    PubMed    



  180. Experts Discuss COVID-19-Vaccine Questions, School Openings, and More.
    JAMA. 2021 Mar 17. pii: 2777786. doi: 10.1001/jama.2021.4121.
    PubMed    


  181. RUBIN R
    COVID-19 Vaccines vs Variants-Determining How Much Immunity Is Enough.
    JAMA. 2021 Mar 17. pii: 2777785. doi: 10.1001/jama.2021.3370.
    PubMed    


  182. WILENSKY GR
    2020 Revealed How Poorly the US Was Prepared for COVID-19-and Future Pandemics.
    JAMA. 2021;325:1029-1030.
    PubMed    


  183. BOYARSKY BJ, Werbel WA, Avery RK, Tobian AAR, et al
    Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients.
    JAMA. 2021 Mar 15. pii: 2777685. doi: 10.1001/jama.2021.4385.
    PubMed    


  184. WILF-MIRON R, Myers V, Saban M
    Incentivizing Vaccination Uptake: The "Green Pass" Proposal in Israel.
    JAMA. 2021 Mar 15. pii: 2777686. doi: 10.1001/jama.2021.4300.
    PubMed    


  185. STEPHENSON KE, Le Gars M, Sadoff J, de Groot AM, et al
    Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19.
    JAMA. 2021 Mar 11. pii: 2777598. doi: 10.1001/jama.2021.3645.
    PubMed     Abstract available


  186. CHRISTIE A, Mbaeyi SA, Walensky RP
    CDC Interim Recommendations for Fully Vaccinated People: An Important First Step.
    JAMA. 2021 Mar 10. pii: 2777536. doi: 10.1001/jama.2021.4367.
    PubMed    


  187. BLUMENTHAL KG, Robinson LB, Camargo CA Jr, Shenoy ES, et al
    Acute Allergic Reactions to mRNA COVID-19 Vaccines.
    JAMA. 2021 Mar 8. pii: 2777417. doi: 10.1001/jama.2021.3976.
    PubMed    


  188. MOORE JP
    Approaches for Optimal Use of Different COVID-19 Vaccines: Issues of Viral Variants and Vaccine Efficacy.
    JAMA. 2021 Mar 4. pii: 2777390. doi: 10.1001/jama.2021.3465.
    PubMed    


  189. DEL RIO C, Malani P
    COVID-19 in 2021-Continuing Uncertainty.
    JAMA. 2021 Mar 4. pii: 2777391. doi: 10.1001/jama.2021.3760.
    PubMed    


  190. MURRAY CJL, Piot P
    The Potential Future of the COVID-19 Pandemic: Will SARS-CoV-2 Become a Recurrent Seasonal Infection?
    JAMA. 2021 Mar 3. pii: 2777343. doi: 10.1001/jama.2021.2828.
    PubMed    


  191. SAADAT S, Tehrani ZR, Logue J, Newman M, et al
    Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2.
    JAMA. 2021 Mar 1. pii: 2777171. doi: 10.1001/jama.2021.3341.
    PubMed    


  192. LIVINGSTON EH, Malani PN, Creech CB
    The Johnson & Johnson Vaccine for COVID-19.
    JAMA. 2021 Mar 1. pii: 2777172. doi: 10.1001/jama.2021.2927.
    PubMed    


    February 2021
  193. CREECH CB, Walker SC, Samuels RJ
    SARS-CoV-2 Vaccines.
    JAMA. 2021 Feb 26. pii: 2777059. doi: 10.1001/jama.2021.3199.
    PubMed    


  194. GHARPURE R, Patel A, Link-Gelles R
    First-Dose COVID-19 Vaccination Coverage Among Skilled Nursing Facility Residents and Staff.
    JAMA. 2021 Feb 24. pii: 2777023. doi: 10.1001/jama.2021.2352.
    PubMed    


  195. RUBIN R
    Pregnant People's Paradox-Excluded From Vaccine Trials Despite Having a Higher Risk of COVID-19 Complications.
    JAMA. 2021 Feb 24. pii: 2777024. doi: 10.1001/jama.2021.2264.
    PubMed    


  196. RUBIN R
    The Price of Success-How to Evaluate COVID-19 Vaccines When They're Available Outside of Clinical Trials.
    JAMA. 2021 Feb 18. pii: 2776787. doi: 10.1001/jama.2021.0641.
    PubMed    


  197. WALENSKY RP, Walke HT, Fauci AS
    SARS-CoV-2 Variants of Concern in the United States-Challenges and Opportunities.
    JAMA. 2021 Feb 17. pii: 2776739. doi: 10.1001/jama.2021.2294.
    PubMed    


  198. KUEHN BM
    High-Income Countries Have Secured the Bulk of COVID-19 Vaccines.
    JAMA. 2021;325:612.
    PubMed    


  199. SHARFSTEIN JM, Goodman JL, Borio L
    The US Regulatory System and COVID-19 Vaccines: The Importance of a Strong and Capable FDA.
    JAMA. 2021 Feb 15. pii: 2776658. doi: 10.1001/jama.2021.1961.
    PubMed    


  200. SHIMABUKURO TT, Cole M, Su JR
    Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021.
    JAMA. 2021 Feb 12. pii: 2776557. doi: 10.1001/jama.2021.1967.
    PubMed    



  201. Experts Discuss COVID-19-Vaccine Doses, Virus Variants, and More.
    JAMA. 2021 Feb 10. pii: 2776539. doi: 10.1001/jama.2021.1101.
    PubMed    


  202. BIANCHI DW, Kaeser L, Cernich AN
    Involving Pregnant Individuals in Clinical Research on COVID-19 Vaccines.
    JAMA. 2021 Feb 10. pii: 2776540. doi: 10.1001/jama.2021.1865.
    PubMed    


  203. ADHIKARI EH, Spong CY
    COVID-19 Vaccination in Pregnant and Lactating Women.
    JAMA. 2021 Feb 8. pii: 2776449. doi: 10.1001/jama.2021.1658.
    PubMed    


  204. RASMUSSEN SA, Jamieson DJ
    Pregnancy, Postpartum Care, and COVID-19 Vaccination in 2021.
    JAMA. 2021 Feb 8. pii: 2776447. doi: 10.1001/jama.2021.1683.
    PubMed    


  205. MEISSNER HC
    A Viral Pandemic, Vaccine Safety, and Compensation for Adverse Events.
    JAMA. 2021 Feb 5. pii: 2776308. doi: 10.1001/jama.2020.26792.
    PubMed    


  206. LIVINGSTON EH
    Necessity of 2 Doses of the Pfizer and Moderna COVID-19 Vaccines.
    JAMA. 2021 Feb 3. pii: 2776229. doi: 10.1001/jama.2021.1375.
    PubMed    


    January 2021
  207. JEAN-JACQUES M, Bauchner H
    Vaccine Distribution-Equity Left Behind?
    JAMA. 2021 Jan 29. pii: 2776053. doi: 10.1001/jama.2021.1205.
    PubMed    


  208. MOORE JP, Offit PA
    SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants.
    JAMA. 2021 Jan 28. pii: 2776039. doi: 10.1001/jama.2021.1114.
    PubMed    


  209. LONGHURST CA, Kremer B, Maysent PS
    Rapid Implementation of a Vaccination Superstation.
    JAMA. 2021 Jan 28. pii: 2776038. doi: 10.1001/jama.2021.0801.
    PubMed    


  210. SHIMABUKURO T, Nair N
    Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine.
    JAMA. 2021 Jan 21. pii: 2775646. doi: 10.1001/jama.2021.0600.
    PubMed    


  211. KUEHN BM
    Drop in Vaccination Causes Surge in Global Measles Cases, Deaths.
    JAMA. 2021;325:213.
    PubMed    


  212. ABBASI J
    Broad, Durable Antibody Response in Universal Flu Vaccine Trial.
    JAMA. 2021;325:121.
    PubMed    


  213. LARGENT EA, Miller FG
    Problems With Paying People to Be Vaccinated Against COVID-19.
    JAMA. 2021 Jan 6. pii: 2775005. doi: 10.1001/jama.2020.27121.
    PubMed    


  214. LAURING AS, Hodcroft EB
    Genetic Variants of SARS-CoV-2-What Do They Mean?
    JAMA. 2021 Jan 6. pii: 2775006. doi: 10.1001/jama.2020.27124.
    PubMed    


  215. GOSTIN LO
    A 7-Point Action Agenda to End the COVID-19 Pandemic for President-elect Biden.
    JAMA. 2021;325:17-18.
    PubMed    


    December 2020
  216. GOSTIN LO, Salmon DA, Larson HJ
    Mandating COVID-19 Vaccines.
    JAMA. 2020 Dec 29. pii: 2774712. doi: 10.1001/jama.2020.26553.
    PubMed    


  217. SZILAGYI PG, Thomas K, Shah MD, Vizueta N, et al
    National Trends in the US Public's Likelihood of Getting a COVID-19 Vaccine-April 1 to December 8, 2020.
    JAMA. 2020 Dec 29. pii: 2774711. doi: 10.1001/jama.2020.26419.
    PubMed    


  218. RUBIN R
    Pharmacies Partner With HHS to Provide COVID-19 Vaccines.
    JAMA. 2020;324:2475.
    PubMed    


  219. KUEHN BM
    Global Regulators Set Standards for Safe Vaccines.
    JAMA. 2020;324:2356.
    PubMed    



  220. Experts Discuss COVID-19: Vaccine Allocation, Placebo Groups, and More.
    JAMA. 2020;324:2354-2355.
    PubMed    


  221. KRIST AH, Davidson KW, Mangione CM, Barry MJ, et al
    Screening for Hepatitis B Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2020;324:2415-2422.
    PubMed     Abstract available


  222. JIN J
    Screening for Hepatitis B in Nonpregnant Adolescents and Adults.
    JAMA. 2020;324:2452.
    PubMed    


  223. RID A, Lipsitch M, Miller FG
    The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials.
    JAMA. 2020 Dec 14. pii: 2774382. doi: 10.1001/jama.2020.25053.
    PubMed    


  224. VOLPP KG, Loewenstein G, Buttenheim AM
    Behaviorally Informed Strategies for a National COVID-19 Vaccine Promotion Program.
    JAMA. 2020 Dec 14. pii: 2774381. doi: 10.1001/jama.2020.24036.
    PubMed    


  225. JOFFE S
    Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines.
    JAMA. 2020 Dec 14. pii: 2774383. doi: 10.1001/jama.2020.25127.
    PubMed    


  226. PATEL MM, Uyeki TM
    Influenza Vaccine for Patients With High-risk Cardiovascular Disease.
    JAMA. 2020 Dec 4. pii: 2773988. doi: 10.1001/jama.2020.23948.
    PubMed    


  227. VARDENY O, Kim K, Udell JA, Joseph J, et al
    Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial.
    JAMA. 2020 Dec 4. pii: 2773989. doi: 10.1001/jama.2020.23649.
    PubMed     Abstract available


  228. RODRIGUES FMP, Marlow R, Simoes MJ, Danon L, et al
    Association of Use of a Meningococcus Group B Vaccine With Group B Invasive Meningococcal Disease Among Children in Portugal.
    JAMA. 2020;324:2187-2194.
    PubMed     Abstract available


    November 2020
  229. DESAI AN, Majumder MS
    What Is Herd Immunity?
    JAMA. 2020;324:2113.
    PubMed    


  230. LURIE N, Experton B
    How to Leverage the Medicare Program for a COVID-19 Vaccination Campaign.
    JAMA. 2020 Nov 19. pii: 2773348. doi: 10.1001/jama.2020.22720.
    PubMed    


  231. LENIS AT, Lec PM, Chamie K, Mshs MD, et al
    Bladder Cancer: A Review.
    JAMA. 2020;324:1980-1991.
    PubMed     Abstract available


  232. SLOMSKI A
    New Guideline Calls for Cervical Cancer Screening to Begin at Age 25 Years.
    JAMA. 2020 Nov 6. pii: 2772859. doi: 10.1001/jama.2020.21706.
    PubMed    


  233. UYEKI TM
    High-risk Groups for Influenza Complications.
    JAMA. 2020 Nov 2. pii: 2772692. doi: 10.1001/jama.2020.21869.
    PubMed    


  234. UYEKI TM, Santoli J, Jernigan DB
    Preparing for the 2020-2021 Influenza Season.
    JAMA. 2020 Nov 2. pii: 2772691. doi: 10.1001/jama.2020.21849.
    PubMed    


    October 2020
  235. JAKLEVIC MC
    Nursing Homes' Next Test-Vaccinating Workers Against COVID-19.
    JAMA. 2020 Oct 28. pii: 2772581. doi: 10.1001/jama.2020.21354.
    PubMed    


  236. BELL BP, Romero JR, Lee GM
    Scientific and Ethical Principles Underlying Recommendations From the Advisory Committee on Immunization Practices for COVID-19 Vaccination Implementation.
    JAMA. 2020 Oct 22. pii: 2772326. doi: 10.1001/jama.2020.20847.
    PubMed    


  237. LEE GM, Romero JR, Bell BP
    Postapproval Vaccine Safety Surveillance for COVID-19 Vaccines in the US.
    JAMA. 2020 Oct 16. pii: 2772137. doi: 10.1001/jama.2020.19692.
    PubMed    


  238. GOODMAN JL, Grabenstein JD, Braun MM
    Answering Key Questions About COVID-19 Vaccines.
    JAMA. 2020 Oct 16. pii: 2772138. doi: 10.1001/jama.2020.20590.
    PubMed    


  239. PATEL MM, Jackson ML, Ferdinands J
    Postlicensure Evaluation of COVID-19 Vaccines.
    JAMA. 2020 Oct 16. pii: 2772136. doi: 10.1001/jama.2020.19328.
    PubMed    


  240. SCHMIDT H, Gostin LO, Williams MA
    Is It Lawful and Ethical to Prioritize Racial Minorities for COVID-19 Vaccines?
    JAMA. 2020 Oct 14. pii: 2771874. doi: 10.1001/jama.2020.20571.
    PubMed    



  241. Influenza Vaccine for 2020-2021.
    JAMA. 2020 Oct 2. pii: 2771510. doi: 10.1001/jama.2020.19507.
    PubMed    


    September 2020
  242. STEPHENS DS, McElrath MJ
    COVID-19 and the Path to Immunity.
    JAMA. 2020 Sep 11. pii: 2770758. doi: 10.1001/jama.2020.16656.
    PubMed    


    August 2020
  243. SOLOMON DA, Sherman AC, Kanjilal S
    Influenza in the COVID-19 Era.
    JAMA. 2020 Aug 14. pii: 2769676. doi: 10.1001/jama.2020.14661.
    PubMed    


    July 2020
  244. WIERSINGA WJ, Rhodes A, Cheng AC, Peacock SJ, et al
    Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.
    JAMA. 2020 Jul 10. pii: 2768391. doi: 10.1001/jama.2020.12839.
    PubMed     Abstract available


  245. DESAI AN, Kim AY
    Management of Hepatitis A in 2020-2021.
    JAMA. 2020 Jul 6. pii: 2768154. doi: 10.1001/jama.2020.4017.
    PubMed    


    May 2020
  246. DEL RIO C, Malani P
    Translating Science on COVID-19 to Improve Clinical Care and Support the Public Health Response.
    JAMA. 2020 May 22. pii: 2766600. doi: 10.1001/jama.2020.9252.
    PubMed    


  247. HALL MA, Studdert DM
    Privileges and Immunity Certification During the COVID-19 Pandemic.
    JAMA. 2020 May 6. pii: 2765835. doi: 10.1001/jama.2020.7712.
    PubMed    


  248. PERSAD G, Emanuel EJ
    The Ethics of COVID-19 Immunity-Based Licenses ("Immunity Passports").
    JAMA. 2020 May 6. pii: 2765836. doi: 10.1001/jama.2020.8102.
    PubMed    


    February 2020
  249. WONG JEL, Leo YS, Tan CC
    COVID-19 in Singapore-Current Experience: Critical Global Issues That Require Attention and Action.
    JAMA. 2020 Feb 20. pii: 2761890. doi: 10.1001/jama.2020.2467.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: